Teva Pharmaceuticals Europe BV

Medicines for Europe - https://www.medicinesforeurope.com/

EFPIA - https://www.efpia.eu/about-us/membership/

Within CEFIC :
--> EFCG (European Fine Chemicals Group - a CEFIC group) - https://efcg.cefic.org/
--> APIC (Active Pharmaceuticals Ingredients Committee) - https://www.apic.cefic.org/

None declared

Promotes their own interests or the collective interests of their members

Jan 2022 - Dec 2022

600,000€ - 699,999€

None declared

600,000€ - 699,999€

Brussels office is composed of 3 people. 1 person spending 75% of their time on policy and advocacy activities and 2 person spending 50% of their time. 1 additional expert from the company spends 25% of her time on activities within the scope of the Register. Financial information includes relevant project costs, the relevant part of trade organisation fees together with our office facilities and other consulting fees.

none

N/A

- Sustainability, Quality and Access to healthcare systems
- eHealth / mHealth
- Industrial policy Initiatives
- Trade agreements
- IP measures
- Corporate social responsibility
- Human medicines Regulatory Affairs

None declared

3 meetings found. Download meetings

The list below covers meetings with Commissioners/Cabinet members/Directors-general (high-level) Commission meetings published December 2014 to December 2024, and the meetings of Commissioners/Cabinet members/Directors-general and officials holding "management functions" in the Commission published since 1 January 2025. Other lobby meetings with lower-level staff may well have taken place, but the Commission doesn't proactively publish information about these meetings. All information below comes from the Commission and not from the registrant.

1 July 2024: We have noted that some meetings are appearing in duplicate, ie. some meetings seem to be listed twice. This seems to be because the Commission changes some element of a meeting data after the meeting has first been listed, which causes LobbyFacts to register it as a new meeting. We are investigating further.

• Date	16 Jun 2021	Location	online
  Subject	Supply chains for medicines
  Cabinet	Cabinet of Vice-President Margaritis Schinas
  Portfolio	Promoting the European Way of Life
  Attending	Margaritis Schinas (Vice-President) Maria Luisa Llano Cardenal (Cabinet member)
  Other Lobbyists	Fresenius Kabi Deutschland GmbH Bureau Européen des Unions de Consommateurs European Chemical Industry Council European Patients' Forum (EPF) Medichem, S.A. MEDICINES FOR EUROPE SANOFI European Healthcare Distribution Association Leuphana Universität Lüneburg Phamaceutical Group of the European Union The European Association of Hospital Pharmacists European Federation of Pharmaceutical Industries and Associations Novo Nordisk A/S Pfizer Inc.

• Date	20 Oct 2020	Location	Videoconference
  Subject	Production capacity of generic medicines in the EU
  Cabinet	Cabinet of Commissioner Thierry Breton
  Portfolio	Internal Market
  Attending	Thierry Breton (Commissioner) Eszter Batta (Cabinet member)
  Other Lobbyists	MEDICINES FOR EUROPE

• Date	28 Mar 2019	Location	Brussels
  Subject	Developments in the field of digital health
  Cabinet	Cabinet of Commissioner Vytenis Andriukaitis
  Portfolio	Health & Food Safety
  Attending	Annika Nowak (Cabinet member)